The Efficacy of Potassium-competitive Acid Blocker (P-CAB) in Patients With Laryngopharyngeal Reflux Disease: a Double- Blind, Randomized, Placebo-controlled Pilot Study
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Tegoprazan (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 12 May 2023 Status changed from recruiting to completed.
- 03 Aug 2020 New trial record